David Leathers

Bio

Has over 25 years of life science venture investment experience. Before joining Abingworth in 1987 worked at N M Rothschild & Sons and was involved in setting up and managing Biotechnology Investments Limited, whose early stage venture portfolio included Amgen, Genzyme and Immunex. Has primary responsibility for Abingworth’s investor relations. Directorships have included GeneMedicine, GenPharm International and Pharming. Qualified as a Chartered Accountant in 1966.